Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 2/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | IDO1 | P14902 | 3/20 | 0.57 |
| ▸ | AGXT | P21549 | 2/20 | 0.57 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.56 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.56 |
| ▸ | CA4 | P22748 | 1/20 | 0.54 |
| ▸ | MAOB | P27338 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | BCHE | P06276 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | APP | P05067 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28551906 | 1.00 | LTA4H (0.69) | LTA4HTDP1L3MBTL1TSHRIDO1 | |
| SCHEMBL34413 | 0.91 | IDO1 (0.67) | LTA4HTDP1L3MBTL1TSHRIDO1 | |
| SCHEMBL1475481 | 0.89 | IDO1 (0.64) | LTA4HTDP1L3MBTL1TSHRIDO1 | |
| Bromide SCHEMBL28558295 | 0.89 | IDO1 (0.64) | LTA4HTDP1L3MBTL1TSHRIDO1 | |
| Potassium SCHEMBL1477050 | 0.89 | IDO1 (0.64) | LTA4HTDP1L3MBTL1TSHRIDO1 | |
| Hydrochloric Acid SCHEMBL28912134 | 0.89 | IDO1 (0.68) | LTA4HTDP1L3MBTL1TSHRIDO1 | |
| Methoxymethane SCHEMBL28823290 | 0.89 | IDO1 (0.64) | LTA4HTDP1L3MBTL1TSHRIDO1 | |
| Anisole SCHEMBL14879816 | 0.88 | TSHR (0.60) | LTA4HTDP1L3MBTL1TSHRIDO1 | |
| SCHEMBL3036840 | 0.87 | LTA4H (0.69) | LTA4HTDP1L3MBTL1IDO1AGXT | |
| SCHEMBL8338571 | 0.87 | TDP1 (0.77) | LTA4HTDP1L3MBTL1TSHRIDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102600892-B | Application of triarylimidazole compound serving as catalyst in electroorganic synthesis | UNIV BEIJING TECHNOLOGY | 2013-08-21 | — | — | CN | disclosed |
| CN-102600892-A | Application of triarylimidazole compound serving as catalyst in electroorganic synthesis | UNIV BEIJING TECHNOLOGY | 2012-07-25 | — | — | CN | disclosed |
| US-20050261237-A1 | Nucleoside phosphonate analogs | GILEAD SCIENCES, INC. | 2005-11-24 | — | — | US | disclosed |
| US-6320085-B1 | REACTING BENZYL ALCOHOL DERIVATIVE WITH 1 TO 3 MOLAR EQUIVALENTS OF SPECIFIED ALCOHOL IN PRESENCE OF ACID, LEWIS ACID, METAL OXIDE OR METAL CARBONATE, ISOLATING RESULTING ETHER, STABILIZING BY ADDITION OF BASE AND/OR ANTIOXIDANT | AGRO-CHEMIE NOVENYVEDOSZER GYARTO ERTEKESITO EST FORGALMAZO KFT. (HU) | 2001-11-20 | — | — | US | disclosed |
| EP-0939749-B1 | PROCESS FOR THE PREPARATION OF BENZYL-ETHERS | AGRO CHEMIE NOEVENYVEDOESZER G (HU) | 2001-07-18 | — | — | EP | disclosed |
| US-6133403-A | RESOLE MIXTURE INCLUDING A SUBSTITUTED BENZYL ALCOHOL OR ETHER, ACID CURING CATALYST; IMPACT STRENGTH, FLEXIBILITY | BORDEN CHEMICAL, INC. (US) | 2000-10-17 | — | — | US | disclosed |
| EP-0939749-A1 | PROCESS FOR THE PREPARATION OF BENZYL-ETHERS | Agro-Chemie Növenyvedöszer Gyárto Ertékesito Es Forgalmazo KFT. (HU) | 1999-09-08 | — | — | EP | disclosed |
| WO-1998022416-A1 | PROCESS FOR THE PREPARATION OF BENZYL-ETHERS | AGRO-CHEMIE NÖVÉNYVÉDÖSZER GYÁRTÓ ÉRTÉKESITÓ ÉS FORGALMAZÓ KFT. (HU) | 1998-05-28 | — | — | WO | disclosed |
| EP-0664316-A1 | Polycarbonate composition having improved resistance to gamma-ray radiation | TEIJIN LIMITED (JP) | 1995-07-26 | — | — | EP | disclosed |
| EP-0054699-B1 | METHOD FOR THE CATALYTIC HYDROGENOLYSIS OF PARA-SUBSTITUTED BENZALDEHYDE-DIMETHYL ACETALS INTO THE CORRESPONDING BENZYLMETHYL ETHERS | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-03-14 | — | — | EP | disclosed |
| EP-0054699-A2 | Method for the catalytic hydrogenolysis of para-substituted benzaldehyde-dimethyl acetals into the corresponding benzylmethyl ethers | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-06-30 | — | — | EP | disclosed |
| US-4165315-A | CHLORINATION WITH AN N-CHLORO HALOGENATING AGENT | ELI LILLY AND COMPANY (US) | 1979-08-21 | — | — | US | disclosed |
| US-4165316-A | Process for preparing sulfinyl chlorides from penicillin sulfoxides | ELI LILLY AND COMPANY (US) | 1979-08-21 | — | — | US | disclosed |
| US-4115383-A | Alkoxycarbonyl-ethylthio-azetidinones and process for their preparation | ELI LILLY AND COMPANY (US) | 1978-09-19 | — | — | US | disclosed |
| US-4081440-A | Sulfinyl halides and their preparation from penicillin sulfoxides | ELI LILLY AND COMPANY (US) | 1978-03-28 | — | — | US | disclosed |
| US-4079075-A | Primary alkyl esters as mediums for oxidations by phase-transfer catalyzed hypohalites | THE DOW CHEMICAL COMPANY (US) | 1978-03-14 | — | — | US | disclosed |
| US-4075203-A | Process for preparing a 3-exomethylenecepham sulfoxide from penicillin sulfoxides | ELI LILLY AND COMPANY (US) | 1978-02-21 | — | — | US | disclosed |
| US-4048162-A | Process for preparing 3-hydroxy cephalosporins | ELI LILLY AND COMPANY (US) | 1977-09-13 | — | — | US | disclosed |
| US-4008231-A | Preparation of 3-methoxymethylcephalosporins | ELI LILLY AND COMPANY (US) | 1977-02-15 | — | — | US | disclosed |
| US-4008230-A | Process for preparing 3-hydroxy cephalosporins | ELI LILLY AND COMPANY (US) | 1977-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261237-A1 | Nucleoside phosphonate analogs | TYMP, PNP, NUDT1 | LTA4H 3319/4885TDP1 340/4885L3MBTL1 3332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.